Clinical trials
Active, not recruiting Neoplasms trials in Turkey (Türkiye)
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
32 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 1 |
| 2017 | 2 |
| 2018 | 5 |
| 2019 | 3 |
| 2020 | 5 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 5 |
| 2025 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 32 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AbbVie | 7 |
| Genmab | 4 |
| Amgen | 3 |
| AstraZeneca | 3 |
| Çanakkale Onsekiz Mart University | 3 |
| Bayer | 2 |
| Acerta Pharma BV | 1 |
| Astellas Pharma Global Development, Inc. | 1 |
| Cellectar Biosciences, Inc. | 1 |
| Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasms | 32 |
| Lymphoma, Non-Hodgkin | 7 |
| Recurrence | 5 |
| Lymphoma | 4 |
| Lymphoma, Large B-Cell, Diffuse | 4 |
| Breast Neoplasms | 3 |
| Multiple Myeloma | 3 |
| Neoplasm Metastasis | 3 |
| Primary Myelofibrosis | 3 |
| Breast Diseases | 2 |
Trials
Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.